Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14470
Articles
Company
Drug
Mabwell to Present Promising Clinical Data at 2023 ESMO Congress
November 15, 2024
Company
Deals
Sirius Therapeutics Secures USD 60 Million in Series B Financing for siRNA Therapy Development
November 15, 2024
Company
Deals
SciClone Pharmaceuticals Partners with Shanghai Pharmaceutical and Menarini Group
November 15, 2024
Company
Digital
Baidu Launches Interactive AI Medication Instructions Service at Baidu World 2023
November 15, 2024
Company
Deals
Novo Nordisk Strikes $1.3 Billion Deal for KBP Biosciences’ Ocedurenone
November 15, 2024
Company
Deals
Ascentage Pharma and AstraZeneca Expand Collaboration on CLL/SLL Treatment
November 15, 2024
Company
Drug
Asieris Pharma Launches Generic Votrient for Renal Cell Carcinoma in China
November 15, 2024
Company
Drug
BeiGene’s Brukinsa Receives Positive CHMP Opinion for Follicular Lymphoma Treatment
January 6, 2025
Company
Deals
EpimAb Biotherapeutics Licenses Bispecific Antibody Platform to Almirall
November 29, 2024
Company
Deals
MSD Partners with Phanes Therapeutics for Innovative Cancer Combo Therapy
December 10, 2024
Company
Deals
Jiangsu Hengrui Licenses Camrelizumab-Apatinib Combo to Elevar Therapeutics
December 3, 2024
Company
Drug
Eli Lilly’s Tirzepatide Shows Robust Weight Loss Results in Phase III Study
November 15, 2024
1
2
…
861
862
863
864
865
…
1,205
1,206
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?